Cardiff Oncology
CRDF----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Cardiff Oncology(CRDF) predict that the Revenue is 41 K (-62.39%), Miss estimate;the EBIT is -12.85 M (+10.65%), Miss estimate;the EPS is -0.18 (+10%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B62.39%
0.00B28.90%
-0.00B33.49%
EBITMiss expectations
-0.01B10.65%
-0.01B33.86%
-0.00B23.21%
EPSMiss expectations
-0.1810.00%
-0.134332.86%
-0.045722.86%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf